ELANA GERSTEN: Open Payments
NPI 1851868517 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$216 in 7 payments from 7 companies in 2025. Trend: 2023 $2,547 · 2024 $2,999 · 2025 $216
Food & beverage: $216
| Company | Payments | Amount |
|---|---|---|
| ZOLL Respicardia, Inc. | 1 | $70 |
| Medtronic, Inc. | 1 | $55 |
| Novo Nordisk Inc | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Cipher Pharmaceuticals US LLC | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: remede System, PERCEPT PC BRAINSENSE, Wegovy, BENLYSTA, XIFAXAN, Natroba, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
